Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT04530305
Eligibility Criteria:
Inclusion Criteria:
* Patients with RA fulfilling American College of Rheumatology (ACR)/ European league against rheumatism (EULAR) 2010 criteria
* Patients with inadequate response to MTX
* Patients receiving MTX as adjuvant therapy or will receive UPA as monotherapy
Exclusion Criteria:
* Patients with contraindication to upadacitinib
* Patients previously treated with biological DMARDs or JAK inhibitors
* Patients treated with ≥ 10 mg/day of glucocorticoids
* Use of IV glucocorticoids in the previous month
* Previous use of biological DMARDs (TNF inhibitors, rituximab, abatacept, tocilizumab) or JAK inhibitors
* Absence of informed consent
* Pregnancy planned for the duration of the study, Women pregnant or breastfeeding women
* Major protected by law or patient under guardianship
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04530305
Study Brief:
Protocol Section:
NCT04530305